Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aerogen, Inc.
Drug and device maker appoints president and CEO
July 6th, 2005
Aerogen, Inc., (AEGN) announced that John C. Hodgman has joined Aerogen as president and CEO. Jane E. Shaw, PhD, has resigned as CEO, and effective June 30, resigned as chairman of the board; as of that time, Jean-Jacques Bienaime became lead director of Aerogen. Hodgman joined Cygnus, Inc., in 1994, becoming president and CEO in 1998 and also serving as the company's chairman of the board for the last 6 years. "I am delighted to welcome John to Aerogen's senior management team. His expertise, gained from years of practical experience, will be extremely beneficial to Aerogen as we develop and pursue the many opportunities that...
Source: Biotech Week (2005-07-06)
|
